Difference between revisions of "CNS5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(16 intermediate revisions by 2 users not shown)
Line 5: Line 5:
 
If empty (no name is present), please volunteer to create content for that disease!
 
If empty (no name is present), please volunteer to create content for that disease!
  
−
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
+
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
−
 
 
−
<br />
 
 
{| class="wikitable" style="margin:auto"
 
{| class="wikitable" style="margin:auto"
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
 
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
Line 19: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|Astrocystoma, IDH-Mutant
+
|CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
|Disease
 
|Disease
 
|Meenakshi Mehrotra
 
|Meenakshi Mehrotra
Line 30: Line 48:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
+
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 +
|Disease
 +
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
|6/7/2022
 
|6/7/2022
 
|
 
|
Line 39: Line 59:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
+
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 +
|Disease
 +
|Meenakshi Mehrotra
 
|
 
|
 
|
 
|
Line 46: Line 68:
 
|LS
 
|LS
 
|
 
|
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
+
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
 
|-
 
|-
−
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
+
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 +
|Disease
 +
|Scott Smith
 
|6/27/2023
 
|6/27/2023
 
|
 
|
−
|PENDING
+
|COMPLETE
 
|
 
|
 
|LS
 
|LS
Line 57: Line 81:
 
|2021 template added (page created 6/27/23)
 
|2021 template added (page created 6/27/23)
 
|-
 
|-
−
|Angiocentric Glioma||Disease||
+
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 66: Line 92:
 
|
 
|
 
|-
 
|-
−
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
+
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 75: Line 103:
 
|
 
|
 
|-
 
|-
−
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
+
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
−
|
+
|Disease
−
|
+
|Scott Smith
−
|
+
|5/3/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|LS
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
+
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 +
|Disease
 +
|Laveniya Satgunaseelan (Linda Cooley - previous version)
 
|
 
|
 
|
 
|
Line 93: Line 125:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
+
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 +
|Disease
 +
|Xiaolin (Lynn) Hu
 
|2/21/2022
 
|2/21/2022
 
|
 
|
Line 102: Line 136:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
+
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 +
|Disease
 +
|Madina Sukhanova
 
|10/28/2022
 
|10/28/2022
 
|
 
|
Line 111: Line 147:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Infant-Type Hemispheric Glioma||Disease||
+
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 +
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 118: Line 157:
 
|
 
|
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
+
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 +
|Disease
 +
|Jeremy Pulvers
 
|9/13/2022<br />
 
|9/13/2022<br />
 
|
 
|
Line 129: Line 169:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|High-Grade Astrocytoma with Piloid Features||Disease||
+
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 138: Line 180:
 
|
 
|
 
|-
 
|-
−
|Pleomorphic Xanthoastrocytoma||Disease||
+
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 147: Line 191:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Subependymal Giant Cell Astrocytoma||Disease||
+
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 156: Line 202:
 
|
 
|
 
|-
 
|-
−
|Chordoid Glioma||Disease||
+
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 165: Line 213:
 
|
 
|
 
|-
 
|-
−
|Astroblastoma, MN1-Altered||Disease||
+
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 174: Line 224:
 
|
 
|
 
|-
 
|-
−
|Ganglioglioma||Disease||Leila Moayed-Aloei
+
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 +
|Disease
 +
|Leila Moayed-Aloei
 
|6/30/2022
 
|6/30/2022
 
|
 
|
Line 183: Line 235:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Gangliocytoma||Disease||
+
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 192: Line 246:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
+
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 201: Line 257:
 
|
 
|
 
|-
 
|-
−
|Dysembryoplastic Neuroepithelial Tumour||Disease||
+
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 210: Line 268:
 
|
 
|
 
|-
 
|-
−
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
+
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 219: Line 279:
 
|
 
|
 
|-
 
|-
−
|Papillary Glioneuronal Tumour||Disease||
+
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 228: Line 290:
 
|
 
|
 
|-
 
|-
−
|Rosette-Forming Glioneuronal Tumour||Disease||
+
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
−
|
+
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 237: Line 301:
 
|
 
|
 
|-
 
|-
−
|Myxoid Glioneuronal Tumour||Disease||
+
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 246: Line 312:
 
|
 
|
 
|-
 
|-
−
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
+
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 255: Line 323:
 
|
 
|
 
|-
 
|-
−
|Multinodular and Vacuolating Neuronal Tumour||Disease||
+
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 264: Line 334:
 
|
 
|
 
|-
 
|-
−
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
+
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 273: Line 345:
 
|
 
|
 
|-
 
|-
−
|Central Neurocytoma||Disease||
+
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 282: Line 356:
 
|
 
|
 
|-
 
|-
−
|Extraventricular Neurocytoma||Disease||
+
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 291: Line 367:
 
|
 
|
 
|-
 
|-
−
|Cerebellar Liponeurocytoma||Disease||
+
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 300: Line 378:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 309: Line 389:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
−
|
+
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 318: Line 400:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 327: Line 411:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 336: Line 422:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 345: Line 433:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 354: Line 444:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma||Disease||
+
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 363: Line 455:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma, MYCN-Amplified||Disease||
+
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 372: Line 466:
 
|
 
|
 
|-
 
|-
−
|Myxopapillary Ependymoma||Disease||
+
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 381: Line 477:
 
|
 
|
 
|-
 
|-
−
|Subependymoma||Disease||
+
|[[CNS5:Subependymoma|Subependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 390: Line 488:
 
|
 
|
 
|-
 
|-
−
|Choroid Plexus Papilloma||Disease||
+
|CHAPTER 3 (CHOROID PLEXUS TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Atypical Choroid Plexus Papilloma||Disease||
 
−
|
 
−
|
 
−
|
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Choroid Plexus Carcinoma||Disease||
 
 
|
 
|
 
|
 
|
Line 417: Line 519:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
+
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
−
|9/20/21
+
|Disease
 
|
 
|
−
|COMPLETE
 
 
|
 
|
−
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 
−
|9/22/2022
 
−
|2021 template added
 
−
|-
 
−
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
 
 
|
 
|
 
|
 
|
Line 433: Line 529:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
 
 
|
 
|
 
|
 
|
Line 444: Line 541:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
+
|CHAPTER 4 (EMBRYONAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Medulloblastoma, Histologically Defined||Disease||
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 +
|Disease
 +
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 +
|9/20/21
 
|
 
|
 +
|COMPLETE
 
|
 
|
 +
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 +
|9/22/2022
 +
|2021 template added
 +
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|Atypical Teratoid/Rhabdoid Tumour||Disease||
 
 
|
 
|
 
|
 
|
Line 469: Line 582:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Cribriform Neuroepithelial Tumour||Disease||
 
 
|
 
|
 
|
 
|
Line 480: Line 594:
 
|
 
|
 
|-
 
|-
−
|Embryonal Tumour with Multilayered Rosettes||Disease||
+
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 489: Line 605:
 
|
 
|
 
|-
 
|-
−
|CNS Neuroblastoma, FOXR2-Activated||Disease||
+
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 498: Line 616:
 
|
 
|
 
|-
 
|-
−
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
+
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 507: Line 627:
 
|
 
|
 
|-
 
|-
−
|CNS Embryonal Tumour NEC/NOS||Disease||
+
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 516: Line 638:
 
|
 
|
 
|-
 
|-
−
|Pineocytoma||Disease||
+
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 525: Line 649:
 
|
 
|
 
|-
 
|-
−
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
+
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 534: Line 660:
 
|
 
|
 
|-
 
|-
−
|Pineoblastoma||Disease||
+
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
−
|
+
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 543: Line 671:
 
|
 
|
 
|-
 
|-
−
|Papillary Tumour of the Pineal Region||Disease||
+
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 552: Line 682:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
+
|CHAPTER 5 (PINEAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Schwannoma||Disease||
+
|[[CNS5:Pineocytoma|Pineocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 570: Line 713:
 
|
 
|
 
|-
 
|-
−
|Neurofibroma||Disease||
+
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 579: Line 724:
 
|
 
|
 
|-
 
|-
−
|Perineurioma||Disease||
+
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 588: Line 735:
 
|
 
|
 
|-
 
|-
−
|Hybrid Nerve Sheath Tumours||Disease||
+
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 597: Line 746:
 
|
 
|
 
|-
 
|-
−
|Malignant Melanotic Nerve Sheath Tumour||Disease||
+
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 606: Line 757:
 
|
 
|
 
|-
 
|-
−
|Malignant Peripheral Nerve Sheath Tumour||Disease||
+
|CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Schwannoma|Schwannoma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 623: Line 784:
 
|
 
|
 
|
 
|
−
|-
 
−
|Meningioma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Neurofibroma|Neurofibroma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Solitary Fibrous Tumour||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Perineurioma|Perineurioma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Haemangiomas and Vascular Malformations||Disease||
 
 
|
 
|
 
|
 
|
Line 648: Line 809:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 +
|Disease
 
|
 
|
 
|
 
|
−
|-
 
−
|Haemangioblastoma||Disease||
 
 
|
 
|
 
|
 
|
Line 658: Line 820:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Rhabdomyosarcoma||Disease||
 
 
|
 
|
 
|
 
|
Line 669: Line 832:
 
|
 
|
 
|-
 
|-
−
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
+
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 678: Line 843:
 
|
 
|
 
|-
 
|-
−
|CIC-Rearranged Sarcoma||Disease||
+
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 687: Line 854:
 
|
 
|
 
|-
 
|-
−
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
+
|CHAPTER 7 (MENINGIOMA)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Ewing Sarcoma||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Meningioma|Meningioma]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 704: Line 881:
 
|
 
|
 
|
 
|
−
|-
 
−
|Mesenchymal Chondrosarcoma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Chondrosarcoma||Disease||
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Chordoma||Disease||
 
 
|
 
|
 
|
 
|
Line 732: Line 916:
 
|
 
|
 
|-
 
|-
−
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
+
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 741: Line 927:
 
|
 
|
 
|-
 
|-
−
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
+
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 750: Line 938:
 
|
 
|
 
|-
 
|-
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
+
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 759: Line 949:
 
|
 
|
 
|-
 
|-
−
|Immunodeficiency-Associated CNS Lymphomas||Disease||
+
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 768: Line 960:
 
|
 
|
 
|-
 
|-
−
|Lymphomatoid Granulomatosis||Disease||
+
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 777: Line 971:
 
|
 
|
 
|-
 
|-
−
|Intravascular Large B-cell Lymphoma||Disease||
+
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 786: Line 982:
 
|
 
|
 
|-
 
|-
−
|MALT Lymphoma of the Dura||Disease||
+
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 795: Line 993:
 
|
 
|
 
|-
 
|-
−
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
+
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 804: Line 1,004:
 
|
 
|
 
|-
 
|-
−
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
+
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
−
|7/2/2023
+
|Disease
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|MS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|T-cell and NK/T-cell Lymphomas||Disease||
 
 
|
 
|
 
|
 
|
Line 820: Line 1,014:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Chordoma|Chordoma]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Erdheim-Chester Disease||Disease||
 
 
|
 
|
 
|
 
|
Line 831: Line 1,026:
 
|
 
|
 
|-
 
|-
−
|Rosai-Dorfman Disease||Disease||
+
|CHAPTER 9 (MELANOCYTIC TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Juvenile Xanthogranuloma||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 +
|Disease
 
|
 
|
 
|
 
|
Line 848: Line 1,053:
 
|
 
|
 
|
 
|
−
|-
 
−
|Langerhans Cell Histiocytosis||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Histiocytic Sarcoma||Disease||
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Germ Cell Tumours of the CNS||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|-
 +
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 +
|Disease
 
|
 
|
−
|-
 
−
|Adamantinomatous Craniopharyngioma||Disease||
 
 
|
 
|
 
|
 
|
Line 885: Line 1,099:
 
|
 
|
 
|-
 
|-
−
|Papillary Craniopharyngioma||Disease||
+
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 894: Line 1,110:
 
|
 
|
 
|-
 
|-
−
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
+
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 903: Line 1,121:
 
|
 
|
 
|-
 
|-
−
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
+
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 912: Line 1,132:
 
|
 
|
 
|-
 
|-
−
|Pituitary Blastoma||Disease||
+
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 921: Line 1,143:
 
|
 
|
 
|-
 
|-
−
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
+
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 930: Line 1,154:
 
|
 
|
 
|-
 
|-
−
|Metastases to the Meninges||Disease||
+
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 +
|Disease
 +
|Jennie Thurston
 +
|7/2/2023
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|MS
 
|
 
|
 +
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
 +
|-
 +
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 +
|Disease
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
−
|-
 
−
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
 
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 
|
 
|
−
|
 
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|Neurofibromatosis Type 2||Disease||
 
 
|
 
|
 
|
 
|
Line 957: Line 1,187:
 
|
 
|
 
|-
 
|-
−
|Schwannomatosis||Disease||
+
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
−
|
+
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 966: Line 1,198:
 
|
 
|
 
|-
 
|-
−
|Von Hippel-Lindau Syndrome||Disease||
+
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 975: Line 1,209:
 
|
 
|
 
|-
 
|-
−
|Tuberous Sclerosis||Disease||
+
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 984: Line 1,220:
 
|
 
|
 
|-
 
|-
−
|Li-Fraumeni Syndrome||Disease||
+
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 993: Line 1,231:
 
|
 
|
 
|-
 
|-
−
|Cowden Syndrome||Disease||
+
|CHAPTER 11 (GERM CELL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
 
−
|7/2/2023
 
 
|
 
|
−
|PENDING
+
----
−
|
 
−
|LS
 
 
|
 
|
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
----
 
|-
 
|-
−
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
+
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
−
|8/22/2023
+
|Disease
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS/MS
 
 
|
 
|
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
−
|-
 
−
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
 
 
|
 
|
 
|
 
|
Line 1,026: Line 1,261:
 
|
 
|
 
|
 
|
 +
|-
 +
|CHAPTER 12 (TUMOURS OF THE SELLAR REGION
 
|
 
|
 +
----
 
|
 
|
−
|-
+
----
−
|Rhabdoid Tumour Predisposition Syndrome||Disease||
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Carney Complex||Disease||
+
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,047: Line 1,293:
 
|
 
|
 
|-
 
|-
−
|DICER1 Syndrome||Disease||Jennie Thurston
+
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
−
|7/2/2023
+
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS
 
 
|
 
|
−
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
 
|-
 
|-
−
|Familial Paraganglioma Syndromes||Disease||
+
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,065: Line 1,315:
 
|
 
|
 
|-
 
|-
−
|Melanoma-Astrocytoma Syndrome||Disease||
+
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,074: Line 1,326:
 
|
 
|
 
|-
 
|-
−
|Familial Retinoblastoma||Disease||
+
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,083: Line 1,337:
 
|
 
|
 
|-
 
|-
−
|BAP1 Tumour Predisposition Syndrome||Disease||
+
|CHAPTER 13 (METASTASES TO THE CNS)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Fanconi Anaemia||Disease||
+
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,101: Line 1,368:
 
|
 
|
 
|-
 
|-
−
|ELP1-Medulloblastoma Syndrome||Disease||
+
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,110: Line 1,379:
 
|
 
|
 
|-
 
|-
−
|}<br />
+
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
−
{| class="wikitable" style="margin:auto"
+
|
−
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
+
----
−
|-
+
|
−
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
+
----
−
!'''Date Assigned to Author'''
 
−
!'''Target Completion Date'''
 
−
!'''Author Content (Pending or Complete)'''
 
−
!'''Date Completed by Author'''!!'''Associate Editor'''
 
−
!'''Date of Last Editor Review'''
 
−
!'''Notes'''
 
−
|-
 
−
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
−
|Disease
 
−
|Meenakshi Mehrotra
 
−
|6/25/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|Laveniya Satgunaseelan (LS)
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 
−
|Disease
 
−
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
−
|6/7/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 
−
|Disease
 
−
|Meenakshi Mehrotra
 
−
|
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
 
−
|-
 
−
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 
−
|Disease
 
−
|Scott Smith
 
−
|6/27/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added (page created 6/27/23)
 
−
|-
 
−
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 
−
|Disease
 
−
|Laveniya Satgunaseelan (Linda Cooley - previous version)
 
−
|
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 
−
|Disease
 
−
|Xiaolin (Lynn) Hu
 
−
|2/21/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 
−
|Disease
 
−
|Madina Sukhanova
 
−
|10/28/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 
−
|Disease
 
−
|Jeremy Pulvers
 
−
|9/13/2022<br />
 
−
|
 
−
|PENDING
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 
−
|Disease
 
−
|Leila Moayed-Aloei
 
−
|6/30/2022
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|LS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Subependymoma|Subependymoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 
−
|Disease
 
−
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 
−
|9/20/21
 
−
|
 
−
|COMPLETE
 
−
|
 
−
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 
−
|9/22/2022
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineocytoma|Pineocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Schwannoma|Schwannoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Neurofibroma|Neurofibroma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Perineurioma|Perineurioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Meningioma|Meningioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Chordoma|Chordoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 
−
|Disease
 
−
|Jennie Thurston
 
−
|7/2/2023
 
−
|
 
−
|PENDING
 
−
|
 
−
|MS
 
−
|
 
−
|2021 template added
 
−
|-
 
−
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 
−
|Disease
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|
 
−
|-
 
−
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 
−
|Disease
 
−
|
 
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
 
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 
|Disease
 
|Disease
−
|Ngoni Faya (trainee) + Madina Sukhanova
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
 
|-
 
|-
 
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 
|[[CNS5:Schwannomatosis|Schwannomatosis]]
Line 2,279: Line 1,434:
 
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
Line 2,301: Line 1,456:
 
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 
|Disease
 
|Disease
−
|
+
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 
|Disease
 
|Disease
−
|Jennie Thurston
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|7/2/2023
+
|N/A
−
|
+
|N/A
−
|PENDING
+
|N/A
−
|
+
|N/A
−
|LS
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
 
|-
 
|-
 
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 
|Disease
 
|Disease
−
|Jennifer Laffin
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|8/22/2023
+
|N/A
−
|
+
|N/A
−
|PENDING
+
|N/A
−
|
+
|N/A
−
|LS/MS
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
 
|-
 
|-
 
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
Line 2,378: Line 1,533:
 
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 
|Disease
 
|Disease
−
|Jennie Thurston
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|7/2/2023
+
|N/A
−
|
+
|N/A
−
|PENDING
+
|N/A
−
|
+
|N/A
−
|LS
+
|N/A
−
|
+
|N/A
−
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
|N/A
 
|-
 
|-
 
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
Line 2,433: Line 1,588:
 
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 
|Disease
 
|Disease
−
|
+
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
−
|
+
|N/A
 
|-
 
|-
 
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]

Revision as of 16:04, 30 July 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 PENDING Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee), Shashi Shetty (mentor) 6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Meenakshi Mehrotra PENDING LS Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 COMPLETE LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease Scott Smith 5/3/2024 PENDING LS
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan (Linda Cooley - previous version) PENDING LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease Jeremy Pulvers 9/13/2022
 PENDING LS 2021 template added
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Subependymoma Disease
CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City 9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease
CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
CHAPTER 7 (MENINGIOMA)
Meningioma Disease
CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease
CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease
CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease
CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease
CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease
CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Cowden syndrome Disease See DIG5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Constitutional mismatch repair deficiency syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=14753"